Loading clinical trials...
Loading clinical trials...
SF-K002 is a pilot study in patients with moderate to severe COPD suffering from involuntary weight loss. The study is 12 weeks, double-blinded, placebo controlled and the main objective is to study t...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Smartfish AS
NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation
NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)
NCT07112196 · Cancer-associated Cachexia
NCT07635446 · COPD
NCT07245576 · Asthma, COPD
Ladulaas kliniska studier
Borås
Pharmasite
Helsingborg
Pharmasite
Malmo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions